title: The role of the serotonergic system in locomotor recovery after spinal cord injury.
abstract: Serotonin (5-HT), a monoamine neurotransmitter synthesized in various populations of brainstem neurons, plays an important role in modulating the activity of spinal networks involved in vertebrate locomotion. Following spinal cord injury (SCI) there is a disruption of descending serotonergic projections to spinal motor areas, which results in a subsequent depletion in 5-HT, the dysregulation of 5-HT transporters as well as the elevated expression, super-sensitivity and/or constitutive auto-activation of specific 5-HT receptors. These changes in the serotonergic system can produce varying degrees of locomotor dysfunction through to paralysis. To date, various approaches targeting the different components of the serotonergic system have been employed to restore limb coordination and improve locomotor function in experimental models of SCI. These strategies have included pharmacological modulation of serotonergic receptors, through the administration of specific 5-HT receptor agonists, or by elevating the 5-HT precursor 5-hydroxytryptophan, which produces a global activation of all classes of 5-HT receptors. Stimulation of these receptors leads to the activation of the locomotor central pattern generator (CPG) below the site of injury to facilitate or improve the quality and frequency of movements, particularly when used in concert with the activation of other monoaminergic systems or coupled with electrical stimulation. Another approach has been to employ cell therapeutics to replace the loss of descending serotonergic input to the CPG, either through transplanted fetal brainstem 5-HT neurons at the site of injury that can supply 5-HT to below the level of the lesion or by other cell types to provide a substrate at the injury site for encouraging serotonergic axon regrowth across the lesion to the caudal spinal cord for restoring locomotion.
authors.affiliation: The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine Miami, FL, USA ; Department of Neurological Surgery, University of Miami Miller School of Medicine Miami, FL, USA.
authors.forename: Mousumi
authors.initials: M
authors.lastname: Ghosh
authors.affiliation: The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine Miami, FL, USA ; Department of Neurological Surgery, University of Miami Miller School of Medicine Miami, FL, USA ; The Neuroscience Program, University of Miami Miller School of Medicine Miami, FL, USA ; The Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine Miami, FL, USA.
authors.forename: Damien D
authors.initials: DD
authors.lastname: Pearse
mesh_terms: D000818:Animals; D001369:Axons / Q000502:physiology; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D006801:Humans; D008124:Locomotion / Q000502:physiology*; D009416:Nerve Regeneration / Q000502:physiology; D009434:Neural Pathways / Q000503:physiopathology / Q000601:surgery; D011985:Receptors, Serotonin / Q000378:metabolism; D020127:Recovery of Function / Q000502:physiology*; D012701:Serotonin / Q000378:metabolism*; D013116:Spinal Cord / Q000503:physiopathology* / Q000601:surgery; D013119:Spinal Cord Injuries / Q000503:physiopathology* / Q000601:surgery
chemical_list: D011985:Receptors, Serotonin; D012701:Serotonin
keywords: central pattern generators (CPG); locomotion control; serotonin; serotonin receptor agonists; spinal cord